Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -33.78x is 93% above its 1-year average of -462.86x, near the high end of its 1-year range (-2638.06x–-22.34x).
21.41% below its 12-month average of -27.82x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -23.43x.
INTEREST COVERAGE RATIO
-33.78x
INTEREST COVERAGE RATIO AVG TTM
-27.82x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-21.41%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
-483.42%
vs the sector median at left
MoonLake Immunotherapeutics
Market Cap
$938.92M
Interest Coverage Ratio
-33.78x
TTM Avg
-27.82x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$931.25M
Interest Coverage Ratio
-30.90x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$949.00M
Interest Coverage Ratio
-200.81x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$950.17M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$919.80M
Interest Coverage Ratio
-9479.76x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$915.21M
Interest Coverage Ratio
N/A
TTM Avg
204.36x
3Y Avg
142.82x
5Y Avg
142.82x
Market Cap
$966.65M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$898.03M
Interest Coverage Ratio
2.21x
TTM Avg
2.21x
3Y Avg
2.21x
5Y Avg
5.08x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | $938.92M | -33.78x | -27.82x | N/A | N/A |
| CeriBell, Inc. (CBLL)vs › | $931.25M | -30.90x | N/A | N/A | N/A |
| Kura Oncology, Inc. (KURA)vs › | $949.00M | -200.81x | N/A | N/A | N/A |
| Seaport Therapeutics, Inc. Common Stock (SPTX)vs › | $950.17M | N/A | N/A | N/A | N/A |
| Savara Inc. (SVRA)vs › | $952.91M | N/A | N/A | N/A | N/A |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $919.80M | -9479.76x | N/A | N/A | N/A |
| HealthStream, Inc. (HSTM)vs › | $915.21M | N/A | 204.36x | 142.82x | 142.82x |
| Aktis Oncology, Inc. (AKTS)vs › | $966.65M | N/A | N/A | N/A | N/A |
| Bioventus Inc. (BVS)vs › | $898.03M | 2.21x | 2.21x | 2.21x | 5.08x |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $979.98M | N/A | N/A | N/A | N/A |
Interest Coverage
-33.8x
Debt/Equity
0.24
Current Ratio
12.56
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -23.43x |
| 2026-03-31 | -30.86x |
| 2025-12-31 | -32.69x |
| 2025-09-30 | -22.34x |
| 2025-06-30 | -29.80x |
| 2025-03-31 | -2638.06x |
